Changes

Jump to navigation Jump to search
key issue and case
''Abigail Alliance v. Von Eschenbach'' was a lawsuit brought by a coalition of patients and a patient-advocacy group to establish a constitutional right to greater access to experimental drugs by patients having terminal diseases.

The plaintiffs claimed that the [[Food and Drug Administration]] places unconstitutional obstacles in the way dying patients who have run out of other treatment options.

The patient-advocacy group, the Abigail Alliance for Better Access to Developmental Drugs, remarked that:<ref>http://www.bloomberg.com/apps/news?pid=20601103&sid=atnVIGEgRQt4&refer=us</ref>

:"Huge numbers of Americans die each year after being denied access to developmental drugs that might have prolonged their lives -- drugs that, in many instances, later received FDA marketing approval."

The plaintiffs found initial success in a 2-1 decision in their favor by the Court of Appeals for the [[D.C. Circuit]]. However, an [[en banc]] sitting of that court then overwhelming reversed that initial panel decision, and held that there should not be a new constitutional right to potentially lifesaving treatment. The court expressed concern that a new constitutional right may become a slippery slope to demand [[stem cell]] research or other controversial and unproven treatments.

The plaintiffs then petitioned the [[U.S. Supreme Court]] for review of their case, in the hope of overturning the decision against them. On January 14, 2008, the Supreme Court refused to [[grant certiorari]] to consider overturning the lower court decision.<ref>http://www.baltimoresun.com/news/nation/bal-te.fda15jan15,0,7129554.story</ref>

== References ==

<references/>
Anthony, Irenaeus, Siteadmin, apieditor, Bureaucrats, Check users, nsAm_Govt_101RO, nsAm_Govt_101RW, nsAm_Govt_101_ta, nsJudgesRO, nsJudgesRW, nsJudges_talkRO, nsJudges_talkRW, nsTeam2RO, nsTeam2RW, nsTeam2_talkRO, nsTeam2_talkRW, oversight, Administrators
126,747

edits

Navigation menu